STOCK TITAN

LeMaitre to Participate at Upcoming Investor Conferences in March

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
LeMaitre Vascular, Inc. (LMAT) will participate in four investor conferences in March 2024, including Oppenheimer Healthcare MedTech & Services Conference, Barclays Global Healthcare Conference, Roth Conference, and KeyBanc Life Sciences & MedTech Investor Forum.
Positive
  • None.
Negative
  • None.

BURLINGTON, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.

Oppenheimer 34th Annual Healthcare MedTech & Services Conference (Virtual)
Tuesday, March 12, 2024
David Roberts, President, will present at 11:20 AM EDT

Barclays Global Healthcare Conference
Thursday, March 14, 2024
Loews Miami Beach Hotel, Miami Beach, FL
David Roberts, President, will present at 10:15 AM EDT

36th Annual Roth Conference 2024
Tuesday, March 19, 2024
The Ritz Carlton, Laguna Niguel located in Dana Point, CA
JJ Pellegrino, Chief Financial Officer, will present at 11 AM PDT

KeyBanc Life Sciences & MedTech Investor Forum (Virtual)
Wednesday, March 20, 2024
David Roberts, President, will present at 11:15 AM EDT

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. For more information about the Company, please visit www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.


LeMaitre Vascular, Inc. (LMAT) will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference on Tuesday, March 12, 2024.

David Roberts, President, will present at the Barclays Global Healthcare Conference for LeMaitre Vascular, Inc. (LMAT) on Thursday, March 14, 2024.

The 36th Annual Roth Conference 2024 for LeMaitre Vascular, Inc. (LMAT) will take place at The Ritz Carlton, Laguna Niguel located in Dana Point, CA on Tuesday, March 19, 2024.

LeMaitre Vascular, Inc. (LMAT) will participate in the KeyBanc Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024.
Lemaitre Vascular Inc

NASDAQ:LMAT

LMAT Rankings

LMAT Latest News

LMAT Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
US
Burlington

About LMAT

lemaitre vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. the company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. the company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. the company is listed on nasdaq.